Assessing the efficacy and safety of gemcitabine-induced thrombocytopenia/neutropenia and thrombocytopenia interventions in zebrafish

Jialong Deng; Ziyuan Zhou; Wangjun Liao; Qing Lin; Yiyue Zhang

doi:10.1016/j.jgg.2024.06.009

Volume 51 Issue 9

Sep. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2024 > 51(9): 970-973

PDF( 816 KB)

Assessing the efficacy and safety of gemcitabine-induced thrombocytopenia/neutropenia and thrombocytopenia interventions in zebrafish

doi: 10.1016/j.jgg.2024.06.009

1. Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China;
2. Department of Hematology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong 528200, China;
3. Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China;
4. Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;
5. Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China;
6. Department of Hematology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong 528200, China;
7. Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China

Funds:

This work was supported by Guangdong Basic and Applied Basic Research Foundation (2024B1515040019), the National Natural Science Foundation of China (32161160326, 32270875, and 32370874), the National Key R&D Program of China (2023YFA1800100), and the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019).

Received Date: 2024-05-27
Accepted Date: 2024-06-19
Rev Recd Date: 2024-06-18

Available Online: 2025-06-06

Publish Date: 2024-06-24

Abstract

FullText(HTML)

References(20)

References

Bjorn, N., Jakobsen, I., Lotfi, K., Green, H., 2020. Single-cell RNA sequencing of hematopoietic stem and progenitor cells treated with gemcitabine and carboplatin. Genes 11, 549.

Blayney, D.W., Schwartzberg, L., 2022. Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: a review. Cancer Treat Rev. 109, 102427.

Hilmi, M., Ederhy, S., Waintraub, X., Funck-Brentano, C., Cohen, A., Vozy, A., Lebrun-Vignes, B., Moslehi, J., Nguyen, L.S., Salem, J.-E., 2020. Cardiotoxicity associated with gemcitabine: literature review and a pharmacovigilance study. Pharmaceuticals 13, 325.

Jin, H., Sood, R., Xu, J., Zhen, F., English, M.A., Liu, P.P., Wen, Z., 2009. Definitive hematopoietic stem/progenitor cells manifest distinct differentiation output in the zebrafish VDA and PBI. Development 136, 647-654.

Kissa, K., Murayama, E., Zapata, A., Cortes, A., Perret, E., Machu, C., Herbomel, P., 2008. Live imaging of emerging hematopoietic stem cells and early thymus colonization. Blood 111, 1147-1156.

Lahoz-Beneytez, J., Elemans, M., Zhang, Y., Ahmed, R., Salam, A., Block, M., Niederalt, C., Asquith, B., Macallan, D., 2016. Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives. Blood 127, 3431-3438.

Li, Y., Sun, L., Li, F., Li, Y., Hou, Y., Meng, Y., Fan, X., Cheng, Y., Hua, F., 2022. Recombinant thrombopoietin effectively shortens the time to response and increases platelet counts in elderly patients with severe immune thrombocytopenia. J. Clin. Med. 11, 5763.

Lin, H.-F., Traver, D., Zhu, H., Dooley, K., Paw, B.H., Zon, L.I., Handin, R.I., 2005. Analysis of thrombocyte development in CD41-GFP transgenic zebrafish. Blood 106, 3803-3810.

Lin, Q., Zhou, R., Meng, P., Wu, L., Yang, L., Liu, W., Wu, J., Cheng, Y., Shi, L., Zhang, Y., 2022. Establishment of a Bernard-Soulier syndrome model in zebrafish. Haematologica 107, 1655.

Macaulay, I.C., Svensson, V., Labalette, C., Ferreira, L., Hamey, F., Voet, T., Teichmann, S.A., Cvejic, A., 2016. Single-cell RNA-sequencing reveals a continuous spectrum of differentiation in hematopoietic cells. Cell Rep. 14, 966-977.

Marra, A., Curigliano, G., 2021. Adjuvant and neoadjuvant treatment of triple-negative breast cancer with chemotherapy. Cancer J. 27, 41-49.

Okusaka, T., Nakachi, K., Fukutomi, A., Mizuno, N., Ohkawa, S., Funakoshi, A., Nagino, M., Kondo, S., Nagaoka, S., Funai, J., 2010. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br. J. Cancer 103, 469-474.

Rohila, D., Park, I.H., Pham, T.V., Weitz, J., Hurtado de Mendoza, T., Madheswaran, S., Ishfaq, M., Beaman, C., Tapia, E., Sun, S., et al., 2023. Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma. Cancer Res. 83, 2675-2689.

Saito, Y., Takekuma, Y., Kobayashi, M., Komatsu, Y., Sugawara, M., 2021. Detection of risk factors related to administration suspension and severe neutropenia in gemcitabine and nab-paclitaxel treatment. Support. Care Cancer 29, 3277-3285.

Shin, J., Kim, M.J., Quan, X., Kim, J.W., Lee, S., Park, S., Jeong, J.Y., Yea, K., 2023. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia. BMC Cancer 23, 490.

Siegel, R.L., Miller, K.D., Wagle, N.S., Jemal, A., 2023. Cancer statistics, 2023. CA A Cancer J. Clin. 73, 17-48.

Song, A.B., Al-Samkari, H., 2023. Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Rev. Hematol. 16, 365-375.

Verderame, F., Russo, A., Di Leo, R., Badalamenti, G., Santangelo, D., Cicero, G., Valerio, M., Gulotta, G., Tomasello, G., Gebbia, N., 2006. Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann. Oncol. 17, vii68-vii72.

Wu, Y., Aravind, S., Ranganathan, G., Martin, A., Nalysnyk, L., 2009. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007. Clin. Therapeut. 31, 2416-2432.

Xu, Y., Song, X., Du, F., Zhao, Q., Liu, L., Ma, Z., Lu, S., 2018. A randomized controlled study of rhTPO and rhIL-11 for the prophylactic treatment of chemotherapy-induced thrombocytopenia in non-small cell lung cancer. J. Cancer 9, 4718-4725.

Relative Articles

Supplements(0)

Cited By

Proportional views